E-Cigarettes: Risk Assessment and Possible uses for Patients with Severe COPD - An Update (GJARM) - Juniper Publishers

E-Cigarettes: Risk Assessment and Possible uses for  Patients with Severe COPD - An Update by Thomas Hering in GJARM - Juniper Publishers

Taking market data as a basis, e-cigarettes continue to enjoy major success [1]. Topulmonologists it falls to assess this development, to advise patients adequately and if appropriate to support their use. Even though for long-term risk assessment the state of information is still unsatisfactory, their use has become increasingly established. The clearest statement has been that of the Public Health Authority of the British government: this clear statement published 2015 on e-cigarettes classified their global risk as extremely positive compared to tobacco cigarettes. The risk from consumption of e-cigarettes is assessed as one twentieth of the risk of tobacco cigarettes [2]. According to this, in a hypothetical world where only e-cigarettes were consumed instead of tobacco cigarettes, after the dropping of tobacco-related morbidity and mortality – the mortality would drop by 95%. Instead of the now roughly120 thousand tobacco-related deaths eg. in Germany [3], we would be left with only 6000 “e-cigarettes-deaths.” That is according to the hypothesis, which speaks for itself

But how should pulmonologists classify their use in consultations, how should they advise patients?

Two significant arguments against e-cigarettes state that they constitute

1. A potential gateway drug for youth…
2. A potential risk of cancer from e-cigarette substances, even if it is less 

https://juniperpublishers.com/gjarm/GJARM.MS.ID.555555.php

https://juniperpublishers.com/gjarm/pdf/GJARM.MS.ID.555555.pdf